-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk Reports Greater Weight Loss And Improved Liver Outcomes With Semaglutide 2.4mg Versus Resmetirom In Real-World MASH Study

Benzinga·11/06/2026 20:08:03
语音播报

https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=919926